Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38+0.04 (+12.53%)
Close on Nov 17, 2026Market cap $48.77MP/E –Yield –
Oncolytics Biotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Oncolytics Biotech's price to sales ratio was 79.2× on Feb 28, 2020, against 6.0× a year earlier. Over the last 2 years it ranged from 5.6× to 180.4×, with a median of 22.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Feb 28, 2020 | 79.2× | −101.2 |
| 2019 | Dec 31, 2019 | 180.4× | +174.9 |
| 2018 | Dec 31, 2018 | 5.6× | – |
See a number that looks wrong?